SGLT2 inhibitors have protective effects on the kidney and the cardiovascular system in T2DM patients. But it varies from patient to patient as there are chances of complications.
This exclusive KOL Interview shares insights on the connection of SGLT2, diabetic ketoacidosis and kidney diseases.
A Challenging Case of Pediatric Brain Abscess
Anatomy & Physiology
1m ago
8
China Reports First Commercial Brain-Computer Interface Implant for Spinal Cord Injury
Anatomy & Physiology
1m ago
0
Rare Triple Procedure Addresses Breast Cancer and Silent Cardiac Disease in One Operation
Cardiology
1m ago
0
Planning Complex Hernia Surgery: A Case-based Discussion
Surgery General
4h ago
3
India Adds Nearly 10,000 MBBS Seats for 2026 to 2027 Academic Session
Allergy & Immunology
5h ago
112
Which Therapy Directly Targets the Pituitary in Cushing Disease?
Endocrinology
5h ago
155